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Abstract
Background: The Depression Network Study (DeNt) is a multicentre study designed to identify
genes and/or loci linked to and/or associated with susceptibility to unipolar depression in Caucasian
families. This study presents the method and socio-demographic details of the first 470 affected
sibling pairs recruited from 8 different sites in Europe and the United States of America.
Methods: Probands fulfilling either the Diagnostic and Statistical Manual 4th edition (DSM-IV) or
the International Classification of Diseases 10th edition (ICD-10) criteria for recurrent unipolar
depression of moderate or severe degree and who had at least one similarly affected sibling were
eligible for the study. Detailed clinical and psychological assessments were undertaken on all
subjects including an interview using the Schedules for Clinical Assessment in Neuropsychiatry.
Blood samples were collected from all participants to extract DNA for linkage analysis.
Results: The different sites used different recruitment strategies depending on local health care
organisation but despite this there was remarkable similarity across sites for the subjects recruited.
Although the Bonn site had significantly older subjects both for age of onset and age at interview,
for the sample as a whole, subjects were interviewed in their mid-40s and had experienced the
onset of their recurrent depression in their 20s. Preliminary genome screening was able to include
929 out of the 944 subjects (98.4%) typed at 932 autosomal and 544 X chromosome markers
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BMC Psychiatry 2004, 4:42 http://www.biomedcentral.com/1471-244X/4/42Conclusions: This paper describes the methodology and the characteristics of the subjects from
the 414 families included in the first wave of genotyping from the multi-site DeNT study. Ultimately
the study aims to collect affected sibling pairs from approximately 1200 families.
Background
Genetic risk factors are well established for major affective
disorders and a recent twin study has suggested that uni-
polar depression has a stronger genetic influence than was
previously thought. McGuffin and colleagues [1] have
estimated that the heritability (i.e. the proportion of lia-
bility explained by genetic risk factors) may be over 70%
in a clinically ascertained twin sample while a population
based twin study resulted in a very similar estimate using
a re-test method of assessing lifetime diagnosis [2].
The majority of studies suggest a relative risk to siblings
(λs) of affective disorder is in the region of 3 [3]. However,
a recent study comparing the siblings of unipolar depres-
sives with the siblings of healthy controls using strict def-
initions of both depression and health found a
substantially higher λs of over 9 [4].
The inheritance of unipolar depression is complex and
involves an inter-play of genetic and environmental fac-
tors. For unipolar depression these include certain types
of severe and threatening life events such as events associ-
ated with humiliation or loss [5,6].
Despite an excess of females to males of about 2 to 1 for
unipolar depression, the heritability in a clinically ascer-
tained sample was the same in men and women [1]. Some
population based twin studies suggest at least some of the
genes conferring liability differ between the sexes [7]
while others do not [8]. Although it has been suggested
that early onset depression is more clearly familial than
later onset, this is not supported by a meta-analysis [9].
The only characteristics of probands associated consist-
ently with higher familiality or heritability are recurrence
of episodes and severity of disorder [1,9].
Previous linkage studies of unipolar depression
Most previous linkage studies have been carried out in
families identified by a bipolar proband and where uni-
polar and bipolar relatives are frequently grouped
together into a broad definition of affective disorders.
Most such studies have focussed on multiple affected
extended pedigrees on the assumption that there may be
a sub-set segregating a gene of major effect. This approach
has been successful in complex disorders such as early
onset Alzheimer's disease and breast cancer. However,
consistent evidence of major gene effects in bipolar disor-
der has not been forth-coming[10]. In addition, the
unknown mode of inheritance creates inherent difficulties
in classic linkage approaches and consequently sib-pair
methods are attractive in the study of complex familial
disorder. An affected sib pair genome scan study of recur-
rent depression has now been published suggesting that
there is a depression susceptibility locus on chromosome
15q [11]. Another genome scan focusing on multiply
affected families found the strongest evidence for linkage
on chromosome 12q [12]. In addition a genome scan of
multiply affected families with alcoholism and in whom
some individuals had depression or co-morbid alcohol-
ism and depression found evidence of a depression linked
locus on chromosome 1p. Clearly these results require
further scrutiny and replication.
Methods
Subjects
Sibling pairs affected with recurrent unipolar depression
were recruited from 8 clinical sites: Aarhus, Denmark;
Bonn, Germany; Dublin, Ireland; Lausanne, Switzerland;
St Louis, USA and London, Cardiff and Birmingham, UK.
In addition, where available, parents of the affected sib-
ling pairs were also included in the study.
Subjects were identified from psychiatric clinics, hospi-
tals, general medical practices and from volunteers
responding to media advertisements. Caucasian subjects
over the age of 18 were included if they had experienced 2
or more episodes of unipolar depression of at least mod-
erate severity separated by at least 2 months of remission
as defined by the Diagnostic and Statistical Manual 4th
edition operational criteria (DSMIV) [13] or the Interna-
tional Classification of Diseases 10th edition operational
criteria (ICD10), for unipolar depression [14]. Probands
were all white and of white European parentage. They
were included in the study if they had at least one biolog-
ical sibling, not a monozygotic twin, over the age of 18
years meeting the same diagnostic criteria. Subjects were
excluded if either sibling had ever fulfilled criteria for
mania, hypomania or schizophrenia.
Subjects were also excluded if they experienced psychotic
symptoms that were mood incongruent or present when
there was no evidence of a mood disturbance. Other
exclusion criteria were intravenous drug use with a life-
time diagnosis of dependency; depression occurring
solely in relation to alcohol or substance abuse or depres-
sion only secondary to medical illness or medication, and
a clear diagnosis of bipolar disorder, schizophrenia,Page 2 of 7
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disorders in first or second-degree relatives.
Clinical assessment
All subjects were interviewed using the Schedules for Clin-
ical Assessment in Neuropsychiatry (SCAN) [15,16].
Items of psychopathology in the SCAN interview were
rated for presence and severity according to the worst and
second worst episodes of depression identified by the sub-
jects. For the purposes of rating severity, subjects were
asked to identify within each of these episodes of depres-
sion a 4–6 week period when their symptoms were at their
worst (peak intensity). The majority of the SCAN items
were coded as follows; 0 – indicates absence of the item,
1 – the item was present but to a mild degree or intermit-
tently throughout the peak intensity 4–6 weeks, 2 – item
moderately severe and present for more the 50% of the
peak intensity period or severe but present for less than
50% of the peak intensity period, 3 – item severe for more
than 50% of the peak intensity period. The computerised
version of the SCAN2.1 is built on top of the IShell sys-
tem, which is a computer aided personal interviewing tool
produced by the World Health Organisation [17] and
which provides diagnoses according to DSMIV and ICD10
operational definitions.
Interviewer training and reliability across sites
All interviewers from each site attended a 4-day SCAN
training course in the UK. Each site also undertook further
inter-rater reliability meetings regularly and annually all
interviewers from all sites took part in a joint inter-rater
reliability exercise.
Ethical approval
All sites obtained ethical approval for the DENT study
within their own countries and institutions. All study par-
ticipants gave written informed consent for participation
in the study.
Self-report questionnaires and other information collected 
from participants at interview
In addition to the SCAN interview all study participants
completed the Eysenck Personality Questionnaire [18]
and a detailed family history of psychiatric and physical
disorders. For the 6 months prior to the worst episode and
6 months prior to the second worst episode as well as the
6 months prior to interview the Brief Life Events Ques-
tionnaire (BLEQ) identified which of 12 types of severe
life events had occurred. These were based on the list pro-
posed by Brugha and colleagues [19] to which childbirth
was added. If such an event had occurred the subject was
also asked to rate the impact of the event as; very distress-
ing (a score of 3), moderately distressing (scored 2) or not
very distressing (scored 1). The BLEQs therefore gave a
summated impact score out of 39 for each 6-month time
frame.
Blood samples
At the time of the SCAN interview interviewers obtained
25 ml of whole blood that was collected in 37.5 ml (EDTA
containing) monovettes. In addition drops of blood were
placed on a Guthrie blood spot card. The blood samples
were labelled with a bar code, gently mixed and stored fro-
zen upright in a -20 degree centigrade freezer pending
DNA extraction.
Phenotypic data analysis
All phenotypic information from interviews and ques-
tionnaires was coded by assigning a number to each sub-
ject, and removing any personal identifying information.
The same codes were used on the blood sample tubes
using a bar code system. The phenotypic information was
first entered on an EXCEL spread sheet after which a data
file was created using Statistical Procedures for the Social
Sciences (SPSS) version 10 for Windows for the statistical
analyses.
Results
Inter-rater agreement for SCAN interview
All the interviewers from all sites took part in a joint inter-
rater reliability exercise (in English) involving both audio-
taped interviews with study subjects and videotaped inter-
views with actors, role-playing a depressed subject. Item
by item kappa statistics for SCAN items, were calculated
comparing each interviewer's ratings against AF's "master"
rating. A mean item by item kappa coefficient across all
the sites of 0.77 (range 0.63 – 0.89) was obtained indicat-
ing a substantial level of inter-rater agreement.
Number of subjects, age at interview, age at illness onset 
and gender by site
For inclusion in the first part of the linkage analysis, 944
affected subjects were genotyped from the 8 study sites as
follows: Aarhus 48, Birmingham 146, Bonn 110, Cardiff
126, Dublin 154, Lausanne, 56, London 111 and St Louis
193. The age at interview and age of illness onset by gen-
der of the subjects recruited at each site are shown in Table
1.
Mean age at interview for both sexes combined for each
site were as follows: Aarhus 44.13 years (standard error of
the mean (SEM)1.5), Birmingham 48.44 years (SEM 1.1),
Bonn 51.46 years (SEM 1.2), Cardiff 44.06 years (SEM
0.9), Dublin 43.32 years (SEM 1.0), Lausanne 47.21 years
(SEM 1.3), London 45.67 years (SEM 1.0), St Louis 47.14
years (SEM 0.9). These mean age differences were statisti-
cally significant (Analysis of variance(ANOVA): F = 6.26
degrees of freedom (df) 7, 936, p < 0.001. Tukey Post hocPage 3 of 7
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Birmingham < St Louis, Lausanne, Birmingham, Bonn).
Mean age at illness onset for both sexes combined per site
were as follows: Aarhus 22.67 years (SEM 1.3), Birming-
ham 24.30 years (SEM 0.8), Bonn 27.28 years (SEM 1.2),
Cardiff 23.47 years (SEM 0.9), Dublin 22.27 years (SEM
0.8), Lausanne 24.85 years (SEM 1.4), London 22.08
years (SEM 1.1), St Louis 18.17 years (SEM 0.8). These
mean age differences were statistically significant
(ANOVA: F = 9.82 df 7, 841 p < 0.001. Tukey Post hoc test:
St Louis, London, Dublin, Aarhus, < London, Dublin,
Aarhus Cardiff, Birmingham, Lausanne < Cardiff, Bir-
mingham, Lausanne, Bonn).
However, there were no significant differences between
sites for the numbers of men and women recruited (see
Table 1) (chi squared test = 6.83 df 7 p = non significant
(ns)).
Number of probands, siblings and other relatives recruited 
by site
Although study participants were mainly affected
proband/sibling pairs, there were a few families where
Table 1: Numbers of male and female subjects, age at interview and age of illness onset by site
Site Gender Number Age at interview (SEM) Age at illness onset (SEM)
Aarhus Female 30 43.53 (2.1) 21.39 (1.8)
Male 18 45.11 (2.0) 24.67 (1.9)
Birmingham Female 104 48.12 (1.3) 23.44 (1.1)
Male 42 49.24 (2.2) 26.19 (1.7)
Bonn Female 86 51.67 (1.3) 28.10 (1.9)
Male 24 50.67 (2.9) 24.24 (4.1)
Cardiff Female 85 43.55 (1.1) 23.76 (1.3)
Male 41 45.12(1.9) 22.92 (1.6)
Dublin Female 110 42.86 (1.2) 21.12 (1.0)
Male 44 44.43 (0.9) 24.97 (2.1)
Lausanne Female 43 48.67 (1.5) 24.69 (2.0)
Male 13 42.39 (2.0) 25.3 (2.1)
London Female 80 45.04 (1.1) 22.63 (1.4)
Male 31 47.29 (2.1) 20.71 (2.0)
St Louis Female 132 47.14 (1.0) 18.44 (0.9)
Male 61 47.15 (1.6) 17.58 (1.5)
SEM = Standard Error of the Mean
Table 2: Number of probands and siblings recruited from each site
Site Gender Number of probands Number of siblings Number of parents
Aarhus Female 11 17 2
Male 12 6 0
Birmingham Female 42 53 9
Male 18 21 3
Bonn Female 38 43 5
Male 12 12 0
Cardiff Female 41 42 2
Male 17 23 1
Dublin Female 54 51 5
Male 14 28 2
Lausanne Female 18 25 0
Male 10 3 0
London Female 37 41 2
Male 13 18 0
St Louis Female 54 63 15
Male 21 33 7Page 4 of 7
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siblings and parents recruited per site is shown in Table 2.
In total there were 369 families with 2 affected siblings, 36
families with 3 affected siblings, 7 families with 4 affected
siblings, and 2 families with 5 affected siblings. In addi-
tion 53 parents were also interviewed and provided blood
for DNA extraction. Thus there were 470 affected sibling
pairs (calculated as number of pairs per family equals
number of affected siblings minus 1).
Gender, age at interview, age at illness onset and marital 
status for all sites combined
Of the 944 subjects, 670 (71%) were female and 274
(29%) were males and hence, the female/male ratio was
2.45:1.
Mean age at interview for all female subjects was 45.40
years (SEM 0.5) and for all males subjects was 45.69 (SEM
0.8). There were no significant gender differences for age
at interview (t = -0.33, df = 477.58, p = ns)
The mean age of illness onset for depressed male subjects
was 22.61 years (SEM 0.7) compared to 22.52 years (SEM
0.4) for depressed female subjects. There was no signifi-
cant sex difference for age of onset.(t = -0.11, df = 443.55
p = ns).
Fifty five percent of male subjects and 61 % female sub-
jects were living with a partner (married or cohabiting),
while 45 % male subjects and 39% female subjects were
living alone (ie separated, widowed, divorced or never
married). Female subjects were significantly more likely to
be living with a partner compared to male subjects. (Chi
squared test = 26.89 df = 1 p < 0.001).
Gender, age at interview, age of illness onset and marital 
status for probands, siblings and parents
There were 295 female and 117 male probands, 335
female and 144 male siblings and 40 female and 13 male
parents included in the total sample. There were no signif-
icantly differences for the gender of probands, siblings or
parents (chi squared test = 0.85, df = 2 p = ns).
The mean age at interview for probands was 45.94 years
(SEM 0.6) and for siblings was 45.80 years (SEM 0.5).
There were no significant differences for age at interview
between probands and their siblings (t = 0.17, df = 872.95
p = ns)
Probands gave a mean age of illness onset of 20.22 years
(SEM 0.6) while siblings reported a mean age of onset of
21.04 years (SEM 0.6). Again these differences were not
statistically significant (t = -0.98, df = 882.93, p = ns)
There were also no significant differences between
probands and their siblings for marital status; 161
probands and 170 siblings were living alone while 242
probands and 290 sibings were living with a partner (chi
squared test = 0.81 df = 1 p = ns).
Genotyping checking
Genotyping was carried out by DeCode and the results
checked for mis-specified relationships by the programs
RELPAIR and Graphical Representation of Relationships
(GRR) at the Institute of Psychiatry. RELPAIR compares
the multipoint probability of the data conditional on the
possible relationships, while GRR calculates the IBS mean
and SD for each pair and plots these values, representing
each type of relative pair using a different colour. Deci-
sions about each problem pair were made on the basis of
the results from both programs, although where there was
discrepancy between the programs the GRR results were
used.
To check genotypes with Mendelian and other pedigree
errors the PEDSTAT and MERLIN programs were used.
These data cleaning processes resulted in 929 individuals
being genotyped at 932 autosomal markers and 44 X
chromosome markers. Success rates for the autosomal
markers were above 61% and for 90% were above 86%.
For the X chromosome the success rate was above 66%.
For individuals the genotyping success rate was above
73% for autosomal markers and 61% for the X
chromosome.
Discussion
Inter-site differences and similarities
The Depression Network study has recruited affected sib-
ling pairs and some of their parents from 7 European and
1 North American site for a linkage analysis of recurrent
unipolar depression. Because of differences in local serv-
ice organisation, different recruitment strategies have
been employed at the different sites. This may account for
the significant differences for age at interview and age at
illness onset between sites. The Bonn site recruited the
oldest sibling pairs, both in terms of when subjects were
interviewed and also when their illnesses had com-
menced. The Bonn subjects had a mean age at interview of
51.46 years compared to the Dublin subjects whose mean
age at interview of 43.31 years was the youngest. Similarly
the Bonn subjects mean age at illness onset was 27.28
years compared to a mean age of illness onset nearly a dec-
ade earlier for the St Louis subjects (18.17 years). It is
noteworthy however that the St Louis sample included
several large affected sibships. Subjects from families
where there are many affected relatives may have a more
genetic form of the disorder that might be contributing to
an earlier age of onset.Page 5 of 7
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there are also considerable similarities across the sites for
the subjects recruited. Subjects have been mainly inter-
viewed in their mid 40s and have experienced the onset of
their recurrent depression in their early to mid 20s. Con-
sequently subjects had on average around 20 years of his-
tory of episodes of depression when interviewed.
Gender ratio and similarlities between probands and 
siblings
As expected the study has shown the same preponderance
of female to male subjects as many other studies with a
gender ratio of around 2.45:1 [4]. However compared to
male subjects, female subjects were significantly more
likely to be living with a partner rather than alone.
We would also not expect to find any significant differ-
ences between probands and siblings in terms of gender,
age at interview, age at illness onset or marital status,
which the results show is the case. Indeed for the purpose
of finding genes for depression we would require siblings
to have experienced similar forms of the illness.
Genotyping checking
Although some subjects were excluded following geno-
typing due to errors that could not be reconciled, this pre-
liminary genome linkage screen was able to include 929
subjects (98.4%) genotyped at 932 autosomal and 544 X
chromosome markers. The results of the whole genome
screen will be presented in due course.
Conclusions
The Depression network study is the first co-ordinated
international collaboration of its kind on the genetics of
depression and one of the largest ever neuropsychiatric
linkage study collection to use a uniform methodology to
define and describe the phenotype. Despite taking place
across eight sites and in six different countries good inter-
rater agreement has been achievable as has good compa-
rability of data.
The study has been designed to overcome the difficulties
that have been encountered in linkage studies of other
psychiatric disorders such as schizophrenia and bipolar
disorder. These started out optimistically with the
assumption that genes of large effect would exist in at least
some multiply affected families. However, after over a
decade of contradictory findings and non replications,
there is now consensus that such families are very rare or
perhaps nonexistent. Rather it seems likely that common
familial psychiatric disorders result from the combined
effect of multiple genes none of which is either necessary
or sufficient to cause the condition [20]. Consequently
large samples are required to have adequate power to
detect genes of comparatively small effect, typically where
the "risk genotype" confers a genotype relative risk of less
than two. Some order is beginning to emerge as a result of
meta-analyses of schizophrenia and bipolar data [21-23]
however meta-analyses are fraught with difficulties result-
ing from differences in diagnostic methods, types of the
family, genetic marker sets used and methods of ascertain-
ment, in addition to the technical problems of how best
to assess statistical significance. It is far preferable to have
large diagnostically and ethnically homogenous data sets
such as the one described here which will ultimately con-
tain well over 1000 families. Family samples of a compa-
rable size are also being collected elsewhere [11]. Until
now studies of the genetics of unipolar depression have
lagged behind those on schizophrenia and bipolar disor-
der but in doing so we have been able to learn from earlier
mistakes. With hope therefore, uncovering the molecular
genetic basis of unipolar depression promises to throw up
less uncertainties and produce more consistency than has
been characteristic of linkage and association studies in
psychiatry.
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